| Literature DB >> 15006365 |
Abstract
A group of novel Bcl-xL/Bak antagonists, based on a terephthalamide scaffold, were designed to mimic the alpha-helical region of the Bak peptide. Good in vitro inhibition potencies in disrupting the Bak/Bcl-xL complex have been observed (terephthalamide 4, K(i)=0.78+/-0.07 microM).Entities:
Mesh:
Substances:
Year: 2004 PMID: 15006365 DOI: 10.1016/j.bmcl.2003.09.096
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823